Читать книгу Anti-Aging Therapeutics Volume XIII - A4M American Academy - Страница 34

Curcumin and B-Sit/AOX Matrix Synergy

Оглавление

There is growing investigation into the use of curcumin for the treatment of cancer. One of the drawbacks is the diminished effect of curcumin with increased levels of insulin. At the same time, an increased level of insulin and insulin resistance are known risk factors for developing prostate and breast cancer, as well as other cancers, and is often a cofactor with cancer patients. B-Sit reduces insulin resistance (most likely by restoring membrane function, especially selective permeability) and regulates insulin production through several mechanisms, one of which is by supporting normal cholesterol homeostasis. In addition, curcumin inhibits cell membrane cholesterol accumulation, furthering the effects of B-Sit, via a different mechanism.

An ideal curcumin will be naturally absorbed, maintain effective serum levels for at least 12-hours in order to allow for 24-hour effective blood levels without frequent dosing, and store in the liver for release throughout the day. In this way, doses of as little as 1,000 mg to 4,000 mg are recommended.

Anti-Aging Therapeutics Volume XIII

Подняться наверх